Blar i Department of Clinical Medicine på forfatter "Sabidó, Meritxell"
-
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis
Butzkueven, Helmut; Hillert, Jan; Soilu-Hänninen, Merja; Ziemssen, Tjalf; Kuhle, Jens; Wergeland, Stig; Magyari, Melinda; Berger, Joseph R.; Moore, Nicholas; Aydemir, Aida; Bezemer, Irene; Sabidó, Meritxell (Journal article; Peer reviewed, 2023)Objectives As part of the CLARION study: (1) characterize the incidence of severe infections, herpes zoster, and malignancies in patients newly initiating cladribine or fingolimod for relapsing multiple sclerosis (MS); ... -
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden
Hakkarainen, Katja Marja; Juuti, Rosa; Burkill, Sarah; Geissbühler, Yvonne; Sabidó, Meritxell; Popescu, Catrinel; Suzart-Woischnik, Kiliana; Hillert, Jan; Artama, Miia; Verkkoniemi-Ahola, Auli; Myhr, Kjell-Morten; Mehtälä, Juha; Bahmanyar, Shahram; Montgomery, Scott; Korhonen, Pasi (Journal article; Peer reviewed, 2020)Background Our aim was to estimate and compare the prevalence of adverse pregnancy outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta (IFNB) and among women with MS unexposed to any MS ...